GCM
IDYA icon

Graham Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Graham Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,762
Closed -$292K – 1365
2026
Q1 		$292K Buy
8,762
+2,921
+50% +$98K 0.01% 823
2025
Q4 		$202K Sell
5,841
-8,871
-60% -$283K ﹤0.01% 1042
2025
Q3 		$400K Buy
+14,712
New +$356K 0.01% 707
2024
Q4 		– Sell
-8,839
Closed -$280K – 1345
2024
Q3 		$280K Buy
+8,839
New +$335K ﹤0.01% 803

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Graham Capital Management's IDYA Position: Q2 2026 in Review

Graham Capital Management sold out of IDEAYA Biosciences (IDYA) in Q2 2026, closing a stake of 8,762 shares — an estimated $292K sold.

Graham Capital Management first reported a position in IDYA in Q3 2024 and held it in 4 quarters. The position peaked at $400K in Q3 2025. 282 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Graham Capital Management reported no remaining IDEAYA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Graham Capital Management sold 8,762 IDEAYA Biosciences shares in Q2 2026, an estimated $292K.
  • Graham Capital Management first reported a position in IDEAYA Biosciences in Q3 2024 and held it in 4 quarters.
  • Graham Capital Management's IDEAYA Biosciences position peaked at $400K in Q3 2025.
  • 282 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.